# LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
> **ANDA208473** · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON PHARMA INC · Approved 2022-04-05
## Drug
- **FDA Application Number:** ANDA208473
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
- **Generic name:** Linagliptin
- **Active ingredients:** LINAGLIPTIN; METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** PRINSTON PHARMA INC
- **First approval:** 2022-04-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208473)
---
*AI Analytics · CC0 1.0*